After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Nektar Therapeutics is $177.27M. A total of 0.91 million shares were traded on the day, compared to an average of 1.76M shares.
In the most recent transaction, Wilson Mark Andrew sold 33,402 shares of NKTR for 0.90 per share on Dec 23 ’24. After the transaction, the Chief Legal Officer now owns 351,892 company shares. In a previous transaction on Dec 24 ’24, Wilson Mark Andrew sold 16,560 shares at 0.89 per share. NKTR shares that Chief Legal Officer owns now total 335,332.
Among the insiders who bought shares, Wilson Mark Andrew acquired of 16,560 shares on Dec 24 ’24 at a per-share price of $0.89. In another insider transaction, Wilson Mark Andrew bought 33,402 shares at $0.90 per share on Dec 23 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NKTR has a high of $1.93 and a low of $0.48.
As of this writing, NKTR has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.18.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NKTR’s latest balance sheet shows that the firm has $733.96M in Cash & Short Term Investments as of fiscal 2021. There were $143.18M in debt and $85.20M in liabilities at the time. Its Book Value Per Share was $0.27, while its Total Shareholder’s Equity was $679.51M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NKTR is Buy with a score of 3.75.
